Checkpoint Capital’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,004,790
| Closed | -$10.6M | – | 15 |
|
|
2024
Q4 | $10.6M | Sell |
1,004,790
-95,210
| -9% | -$1M | 5.37% | 6 |
|
|
2024
Q3 | $14.4M | Sell |
1,100,000
-38,178
| -3% | -$501K | 7.16% | 6 |
|
|
2024
Q2 | $16M | Buy |
1,138,178
+436,791
| +62% | +$6.14M | 9.65% | 4 |
|
|
2024
Q1 | $11.8M | Buy |
701,387
+376,387
| +116% | +$6.36M | 7.92% | 4 |
|
|
2023
Q4 | $4.59M | Buy |
+325,000
| New | +$4.59M | 2.78% | 9 |
|